Optimizing and Advancing SBIRT in Schools

NCT06206161 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21000

Last updated 2025-11-26

No results posted yet for this study

Summary

The goal of this clinical trial is to establish whether brief interventions for alcohol use can be delivered in schools for both indicated prevention and selected prevention, determine if an expanded workforce is an effective model for screening, brief intervention, and referral to treatment (SBIRT) delivery in schools, and explore whether brief intervention effectiveness is comparable in minoritized versus non-minoritized adolescents.

Participants will be students at high schools across Massachusetts. High schools will be randomized to one of four intervention groups. Participants will complete a baseline survey prior to their school-wide screening for SBIRT, and then will complete four follow-up surveys over two years.

Conditions

  • Adolescent Drinking
  • Adolescent Substance Use
  • Risk Behavior, Health

Interventions

BEHAVIORAL

Indicated Prevention, Clinical Staff

Standard brief intervention eligibility criteria involving indicated prevention (i.e., brief interventions delivered to high-risk drinkers only). BIs delivered by standard SBIRT workforce involving school nursing or clinical staff.

BEHAVIORAL

Selective Prevention

Expanded brief intervention eligibility criteria involving selective prevention in addition to indicated prevention (i.e., brief interventions delivered to current drinkers with and without risky alcohol use).

BEHAVIORAL

Expanded Paraprofessional Workforce

Brief interventions delivered by expanded SBIRT workforce involving school nursing or clinical staff and trained paraprofessionals.

Sponsors & Collaborators

  • C4 Innovations, LLC

    collaborator UNKNOWN
  • Harvard University

    collaborator OTHER
  • Patient-Centered Outcomes Research Institute

    collaborator OTHER
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Randi M Schuster, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-11
Primary Completion
2027-11-11
Completion
2027-11-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06206161 on ClinicalTrials.gov